hindustan unilever
Jump to
2309 Results Found
  • Hold Hindustan Unilever; target of Rs 2304: Prabhudas Lilladher Jul 23, 2020 07:09 PM IST

    Hold Hindustan Unilever; target of Rs 2304: Prabhudas Lilladher

    Prabhudas Lilladher recommended hold rating on Hindustan Unilever with a target price of Rs 2304 in its research report dated July 22, 2020.

  • Hold Hindustan Unilever; target of Rs 2300: Emkay Global Financial Jul 23, 2020 07:04 PM IST

    Hold Hindustan Unilever; target of Rs 2300: Emkay Global Financial

    Emkay Global Financial recommended hold rating on Hindustan Unilever with a target price of Rs 2300 in its research report dated July 22, 2020.

  • Hold Hindustan Unilever; target of Rs 2410: ICICI Direct Jul 22, 2020 03:31 PM IST

    Hold Hindustan Unilever; target of Rs 2410: ICICI Direct

    ICICI Direct recommended hold rating on Hindustan Unilever with a target price of Rs 2410 in its research report dated July 22, 2020.

  • Reduce Hindustan Unilever; target of Rs 2016: HDFC Securities Jul 22, 2020 03:26 PM IST

    Reduce Hindustan Unilever; target of Rs 2016: HDFC Securities

    HDFC Securities recommended reduce rating on Hindustan Unilever with a target price of Rs 2016 in its research report dated July 21, 2020.

  • Buy Hindustan Unilever target of Rs 2550: Sharekhan Jul 22, 2020 03:22 PM IST

    Buy Hindustan Unilever target of Rs 2550: Sharekhan

    Sharekhan is bullish on Hindustan Unilever has recommended buy rating on the stock with a target price of Rs 2550 in its research report dated July 21, 2020.

  • Hold Hindustan Unilever; target of Rs 2278: Prabhudas Lilladher Jul 22, 2020 03:12 PM IST

    Hold Hindustan Unilever; target of Rs 2278: Prabhudas Lilladher

    Prabhudas Lilladher recommended hold rating on Hindustan Unilever with a target price of Rs 2278 in its research report dated July 21, 2020.

  • Reduce Hindustan Unilever; target of Rs 2320: Dolat Capital Jul 22, 2020 03:08 PM IST

    Reduce Hindustan Unilever; target of Rs 2320: Dolat Capital

    Dolat Capital recommended reduce rating on Hindustan Unilever with a target price of Rs 2320 in its research report dated July 21, 2020.

  • Buy Hindustan Unilever; target of Rs 2550: Motilal Oswal Jul 22, 2020 02:56 PM IST

    Buy Hindustan Unilever; target of Rs 2550: Motilal Oswal

    Motilal Oswal is bullish on Hindustan Unilever recommended buy rating on the stock with a target price of Rs 2550 in its research report dated July 21, 2020.

  • HUL share price falls 2% post Q1 numbers; Jefferies raises target Jul 22, 2020 09:34 AM IST

    HUL share price falls 2% post Q1 numbers; Jefferies raises target

    Standalone revenue from operations during the quarter stood at Rs 10,560 crore, increasing 4.4 percent compared to Rs 10,114 crore in corresponding period last year.

  • HUL Standalone June 2020 Net Sales at Rs 10,560.00 crore, up 4.41% Y-o-Y Jul 22, 2020 09:31 AM IST

    HUL Standalone June 2020 Net Sales at Rs 10,560.00 crore, up 4.41% Y-o-Y

  • HUL Consolidated June 2020 Net Sales at Rs 10,731.00 crore, up 3.54% Y-o-Y Jul 22, 2020 09:31 AM IST

    HUL Consolidated June 2020 Net Sales at Rs 10,731.00 crore, up 3.54% Y-o-Y

  • HUL Q1 profit up 7% at Rs 1,881 crore, volume contracts 7%; board announces dividend of Rs 9.50 Jul 21, 2020 04:19 PM IST

    HUL Q1 profit up 7% at Rs 1,881 crore, volume contracts 7%; board announces dividend of Rs 9.50

    Volume contracted by 7 percent in June quarter, against street expectations of 11-13 percent contraction.

  • HUL to announce Q1 earnings today; here are key things to watch out for Jul 21, 2020 07:59 AM IST

    HUL to announce Q1 earnings today; here are key things to watch out for

    HUL share price fell 5 percent during the quarter ended June 2020 and rallied 21.3 percent year-to-date against 10 percent rally and 4 percent gains in Nifty FMCG index respectively.

  • Banks, NBFCs, consumption likely to outperform: 3 stocks with 8-15% return in short term Jul 12, 2020 07:45 AM IST

    Banks, NBFCs, consumption likely to outperform: 3 stocks with 8-15% return in short term

    An index is likely to remain sideways in the range of 10,880 to 10,680 in the forthcoming trading week with slightly negative bias.

  • Fairness cream name row: Bombay HC gives interim relief for HUL against Emami Jul 06, 2020 08:48 PM IST

    Fairness cream name row: Bombay HC gives interim relief for HUL against Emami

    HUL in its application said the defendant (Emami) should give it at least seven days prior written notice before initiating any legal proceedings in any court or claiming any interim relief against HUL as threatened in the statements made by Emami.

  • Aatmanirbar Bharat | No import from China: HUL looks for alternative source for raw material Jul 01, 2020 11:07 AM IST

    Aatmanirbar Bharat | No import from China: HUL looks for alternative source for raw material

    Hindustan Unilever has imports from China worth Rs 429 crore

  • Rama Bijapurkar: Fair & Lovely’s rebranding brings new opportunities for HUL and competitors Jun 29, 2020 08:31 AM IST

    Rama Bijapurkar: Fair & Lovely’s rebranding brings new opportunities for HUL and competitors

    This forced churning, like all forced churning, might even do the brand franchise good, and enable it to compete in a more mainstream manner and appeal to a wider audience. The loser in this is a whole lot of consumers who really wanted fairness

  • After HUL, L'Oreal to drop words white, light, fair from its 'skin-evening' products Jun 27, 2020 08:18 PM IST

    After HUL, L'Oreal to drop words white, light, fair from its 'skin-evening' products

    Unilever and L’Oreal are two big players in the global market for skin whitening creams used in many Asian, African and Caribbean countries where fair skin is often considered desirable.

  • HUL completes acquisition of female hygiene brand VWash from Glenmark Jun 26, 2020 11:00 AM IST

    HUL completes acquisition of female hygiene brand VWash from Glenmark

    The acquisition was announced in March and was subject to certain closing conditions, which have now been fulfilled, the FMCG firm said in a filing to BSE.

  • Too early to predict the mid-term impact from novel coronavirus: Hindustan Unilever Jun 15, 2020 04:54 PM IST

    Too early to predict the mid-term impact from novel coronavirus: Hindustan Unilever

    Motilal Oswal remains positive on HUL in the medium term with a Buy rating and target price of Rs 2,400 per share.

  • Buy Hindustan Unilever; target of Rs 2400: Motilal Oswal Jun 15, 2020 07:58 AM IST

    Buy Hindustan Unilever; target of Rs 2400: Motilal Oswal

    Motilal Oswal is bullish on Hindustan Unilever has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated June 09, 2020.

  • Buy Hindustan Unilever Limited target of Rs 2305: Sharekhan May 10, 2020 02:02 PM IST

    Buy Hindustan Unilever Limited target of Rs 2305: Sharekhan

    Sharekhan is bullish on Hindustan Unilever Limited has recommended buy rating on the stock with a target price of Rs 2305 in its research report dated May 08, 2020.

  • HUL share prices jump 3% after Societe Generale buys 1.29 cr shares, Credit Suisse retains outperform call May 08, 2020 10:02 AM IST

    HUL share prices jump 3% after Societe Generale buys 1.29 cr shares, Credit Suisse retains outperform call

    Credit Suisse has maintained its outperform call on the stock with target at Rs 2,400 per share.

  • Societe Generale buys Rs 2,453 crore HUL shares, Anamudi Real ups stake in Sobha May 07, 2020 08:49 PM IST

    Societe Generale buys Rs 2,453 crore HUL shares, Anamudi Real ups stake in Sobha

    Promoter Sameer Gupta continued to buy Apollo Pipes shares for the third consecutive session, acquiring a 1,44,476 shares at Rs 323.73 per share

  • GlaxoSmithKline sells $3.35 billion stake in Hindustan Unilever May 07, 2020 02:35 PM IST

    GlaxoSmithKline sells $3.35 billion stake in Hindustan Unilever

    The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly bets on experimental cancer treatments and future cell and gene therapies amid sluggish revenue growth.

Sections